22821-75-6

Basic information

• Product Name: 4,6-DIMETHOXY-2-PIPERIDIN-4-YLPYRIMIDINE
• Synonyms: 4,6-DIMETHOXY-2-PIPERIDIN-4-YLPYRIMIDINE;3-(Methylsulphonyl)benzonitrile 98%;3-Cyanophenyl methyl sulphone;Benzonitrile,3-(Methylsulfonyl)-;4,6-Dimethoxy-2-(4-piperidinyl)pyrimidine;3-(Methylsulphonyl)benzonitrile98%
• CAS NO: 22821-75-6
• Molecular Formula: C₈H₇NO₂S
• Molecular Weight: 181.21
• Product Categories: Boron, Nitrile, Thio,& TM-Cpds
• Mol File: 22821-75-6.mol
• Article Data: 6

Chemical Properties

• Melting Point: 48-51
• Boiling Point: 378.1 °C at 760 mmHg
• Flash Point: 182.5 °C
• Appearance: /
• Density: 1.32 g/cm³
• Vapor Pressure: 6.45E-06mmHg at 25°C
• Refractive Index: 1.57
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 4,6-DIMETHOXY-2-PIPERIDIN-4-YLPYRIMIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 4,6-DIMETHOXY-2-PIPERIDIN-4-YLPYRIMIDINE(22821-75-6)
• EPA Substance Registry System: 4,6-DIMETHOXY-2-PIPERIDIN-4-YLPYRIMIDINE(22821-75-6)

Safety Data

• Hazard Codes: Xi,T
• Statements: 25
• Safety Statements: 45
• HazardClass: IRRITANT
• Hazardous Substances Data: 22821-75-6(Hazardous Substances Data)

Usage

General Description

4,6-Dimethoxy-2-piperidin-4-ylpyrimidine is a chemical compound with the molecular formula C12H18N4O2. It is a heterocyclic compound containing a pyridine ring and a piperidine ring, both of which are substituted with methoxy groups. 4,6-DIMETHOXY-2-PIPERIDIN-4-YLPYRIMIDINE has potential pharmaceutical applications, as it may have biological activity related to its structure. However, further research is needed to fully understand its properties and potential uses in the pharmaceutical industry.

InChI:InChI=1/C8H7NO2S/c1-12(10,11)8-4-2-3-7(5-8)6-9/h2-5H,1H3

Upstream product

• 98-10-2 benzenesulfonamide 
• 5345-27-7 3-(methylsulfonyl)benzoic acid 
• 35216-39-8 3-(methylsulfonyl)aniline 
• 65052-48-4 3-cyanophenyl methyl sulfide 
• 930-69-8 sodium thiophenolate 
• 150296-23-4 (m-(methylsulfonyl)phenyl)chlorodiazirine 
• 623-26-7 terephthalonitrile 
• 60036-48-8 methyl(3-(methylsulfonyl)phenyl)sulfane 
• 512-56-1 trimethyl phosphite 
• 69113-59-3 3-iodobenzonitrile 
• 34896-80-5 1-bromo-3-methanesulphonylbenzene 
• 557-21-1 dicyanozinc 
• 4025-64-3 3-Carboxybenzenesulfonyl chloride 
• 2976-32-1 1-methanesulfonyl-3-nitro-benzene 

Downstream Products

• 771573-22-9 1-[3-(methylsulfonyl)phenyl]methanamine 
• 150296-24-5 3-methylsulfonylbenzamidine hydrochloride 
• 58123-66-3 3-(methylsulfonyl)-5-nitro-benzoic acid 
• 1154867-12-5 C₉H₁₁NO₃S 
• 939999-41-4 N'-hydroxy-3-(methylsulfonyl)benzimidamide 
• 65052-50-8 6-(3-methanesulfonyl-phenyl)-[1,3,5]triazine-2,4-diamine 
• 150296-23-4 (m-(methylsulfonyl)phenyl)chlorodiazirine 

Relevant articles and documents

Nickel-Catalyzed Reversible Functional Group Metathesis between Aryl Nitriles and Aryl Thioethers

We describe a new functional group metathesis between aryl nitriles and aryl thioethers. The catalytic system nickel/dcype is essential to achieve this fully reversible transformation in good to excellent yields. Furthermore, the cyanide- and thiol-free reaction shows high functional group tolerance and great efficiency for the late-stage derivatization of commercial molecules. Finally, synthetic applications demonstrate its versatility and utility in multistep synthesis.

Methods for the use of inhibitors of cytosolic phospholipase A2 in the treatment of thrombosis

This invention provides methods for the use of substituted indole compounds of the general formula: and pharmaceutically acceptable salt forms thereof. The invention provides methods for the use of the compounds in the treating or preventing thrombosis in a mammal, or preventing progression of symptoms of thrombosis.

Pyrimidine derivatives for the treatment of abnormal cell growth

The present invention relates to a compound of the formula 1 wherein R1-R4 are as defined herein. Such novel pyrimidine derivatives are useful in the treatment of abnormal cell growth, such as cancer, in mammals. This invention also relates to a method of using such compounds in the treatment of abnormal cell growth in mammals, especially humans, and to pharmaceutical compositions containing such compounds.